Studies on the kinetic assessment of changes in TRAIL as a potential predictive and prognostic factor in the serum of patients with stage IIIC and IV epithelial carcinoma (EOC), according to FIGO, or primary peritoneal carcinoma (PPC) eligible for an interval debulking surgery (IDS) were conducted by Gasowska-Bodnar et al. [26]. The gene discussed is TNFSF10; the disease is carcinoma.